Skip to content

Use of blood products in healing of diabetic leg wound

A comparative study of platelet rich plasma versus conventional dressing in management of diabetic foot ulcers in a tertiary care hospital - A randomized control trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/08/020959
Enrollment
72
Registered
2019-08-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

Intervention1: Platelet rich plasma: route ofadministration-PrP would be administered by injecting into the edge of the ulcer. frequency-once in a week for three weeks duration- 4weeks Control Interve

Sponsors

DR G RAY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diabetic Patient with good glycemic control. 2.Ulcer: without any active infection confirmed by pus culture sensitivity or treated with antibiotic therapy 3.Circulation status: with palpable pulses

Exclusion criteria

Exclusion criteria: 1.patients with uncontrolled DM, DKA 2.Active malignancy. 3.Being treated with immunosuppressant drugs. 4.Patient received biological treatment(s) within 30 days. 5.Active infection - if osteomyelitis has been diagnosed.

Design outcomes

Primary

MeasureTime frame
To assess the rapid wound healing in diabetic ulcer,thereby reducing the complications of ulcer. Reduced stay in hospital to improve the quality of lifeTimepoint: wound size is assessed at the end of 1st, 2nd, 3rd and 4th week

Secondary

MeasureTime frame
a) Time period of healing b) Reduction in discharge c)To assess cost effectiveness in the treatment Timepoint: wound size is assessed at the end of 1st, 2nd, 3rd and 4th week

Countries

India

Contacts

Public ContactDr ANAND S

Indira Gandhi Medical College and research institute,puducherry

srivatsanray@yahoo.com9442992948

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026